Live Trading Now Runs in the Same App Clients Use to Open and Fund Accounts
LONDON, Oct. 23, 2026 (GLOBE NEWSWIRE) — EBC Financial Group (EBC) has expanded live trading in the EBC App, bringing…
Journalists Tour Jinan Machine-Tool Plant Where Trainees Work on Real Orders
JINAN, China, Oct. 23, 2026 (GLOBE NEWSWIRE) — Journalists from the Caribbean recently stepped onto the production floor of JIER…
Fishery-PV Complementary Model Lights Up Yellow River Villages in Jinan, China’s Shandong
Information office of Jinan municipal government JINAN, China, Oct. 23, 2026 (GLOBE NEWSWIRE) — Journalists from international media outlets, being…
From nearshore waters to the deep blue: China’s Fuzhou charts a new course in maritime strength
The World Maritime Equipment Conference 2026 FUZHOU, China, Oct. 23, 2026 (GLOBE NEWSWIRE) — The World Maritime Equipment Conference 2026…
Correction: Norsk Hydro: Solid results and strong performance
Hydro’s adjusted EBITDA for the third quarter of 2026 was NOK 9,089 million, up from NOK 5,996 million in the…
SDG Cities Global Conference 2026 to Kick Off on Nov. 2
SHANGHAI, Oct. 23, 2026 (GLOBE NEWSWIRE) — The SDG Cities Global Conference 2026 will be held at the Grand Halls…
Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA
FLORHAM PARK, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing…
Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) — Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today…
ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial
In a 1L EGFR atypical population with more than double the rate of baseline CNS metastases as competitor datasets, enozertinib…
ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026
Preclinical data highlight potential advantages of targeting PRC2 via EED over EZH2, including the emergence of resistance mutations to EZH2…
Turing Award Laureate Joseph Sifakis Visits CaoCao AI Innovation Center, Witnesses Launch of Trustworthy AI Research Project for Robotaxi Curbside Operations
SHANGHAI, China, Oct. 23, 2026 (GLOBE NEWSWIRE) — On October 21, Professor Joseph Sifakis, a Turing Award laureate and Chief…
Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer
Faster and higher expansion of tumor-targeting CD8 T cells associated with longer overall survival in previously treated mismatch repair proficient…
↑